SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.600-8.5%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (4615)11/4/1999 12:59:00 AM
From: chester lee  Read Replies (3) of 10293
 
Bill,

biz.yahoo.com

The Quigley Corporation Comments on News Story Touting a Zinc Spray That Shortens the Common Cold

DOYLESTOWN, Pa., Nov. 2 /PRNewswire/ -- The Quigley Corporation (Nasdaq: QGLY - news), manufacturers and distributors of COLD-EEZE© cold relief products, said today that the public should wait until publication of an accredited study by the manufacturers of Zicam before blindly accepting the alleged results of the unpublished study.

``We have not yet had the opportunity to review the quality and nature of the Zicam study, which was controlled by the Zicam staff at an undisclosed location,' said Guy Quigley, chairman and CEO. ``Therefore, The Quigley Corporation is unable to comment on the efficacy and safety of Zicam's nasal product, since the study was not conducted under strict outside independent accredited institutional conditions as applied to Quigley's patented COLD-EEZE product.'

Quigley noted the following facts:
-- COLD-EEZE is a proven therapy as confirmed in two double-blind, placebo-controlled studies held at The Dartmouth College Cold Clinic and The Cleveland Clinic Foundation.
-- The COLD-EEZE studies were peer reviewed and published in The Journal of International Medical Research and The Annals of Internal Medicine.
-- Most respected Journals embargo study results and disqualify papers about products when their studies are widely broadcast prior to publication. For example, The Quigley Corporation was fully aware of the COLD-EEZE study results months before publication, but the news was embargoed by the Journals.

-- The Quigley Corporation cannot understand the attempt to promote a study that has never been published.
The Quigley Corporation is also responsible for the total funding of the homeopathic proving to establish the safety of Zinc Gluconate, which resulted in Zinc Gluconate receiving a monograph in the Homeopathic Pharmacopoeia of the United States.

``I believe the public -- and the news media -- should use caution until there is an opportunity to review the entire study and its ensuing paper and determine what is fact and what is fiction in this case,' Quigley said.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext